FilingReader Intelligence
Haohai Biological announces flat profit, dividend cut for 2024
March 27, 2025 at 10:03 PM UTC•By FilingReader AI
Shanghai Haohai Biological Technology Co., Ltd. (HKEX: 6826) announced its annual results for the year ended December 31, 2024, reporting revenue of RMB 2,679.67 million, a marginal 1.70% increase year-over-year. Net profit attributable to shareholders remained relatively flat at RMB 420.45 million.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HKEX:6826•Hong Kong Exchange
News Alerts
Get instant email alerts when Shanghai Haohai Biological Technology publishes news
Free account required • Unsubscribe anytime